DONNA BOWERS & ALAN MILLER

Similar documents
Hope. has a new home. Baylor Charles A. Sammons Cancer Center at Dallas

Progress Update June 2017 Lay Summary Funding: $6,000,000 Grant Funded: July 2015 Dream Team Members Dream Team Leader:

Kinds of Case Statements

Finding the Positives in Triple-Negative Breast Cancer:

CYPRESS U CRITICAL UPDATE

Study of Triple-Negative Breast Cancer is Most Cited in AACR Journal

JOINT STATEMENT BY MEMBERS OF THE NATIONAL COMPREHENSIVE CANCER NETWORK PROSTATE CANCER GUIDELINES PANEL

Appropriate Use of Advanced Technologies for Radiation Therapy and Surgery in Oncology. July 20-21, Washington DC

/ NCCN. ACS ( NCC ( NCCN NCCN ACS ACS-2345

DiaTech Oncology, LLC Developer of CorrectChemo Assay

London Regional Cancer Program

METASTATIC BREAST CANCER

Clinical Trials: Advanced or Metastatic Bladder Cancer Wednesday June 22 nd, 2016 Part III: Question and Answer

Opportunity and Challenge

Strategic Direction. At The Kids Cancer Project our vision is to find a cure for kids cancer

Staying on top of the current research landscape with InCites Benchmarking & Analytics: An immuno-oncology case study

San Antonio Breast Cancer Symposium December 5-9, 2017

Research goal is to identify better diagnostic, vaccine and treatment targets for chlamydia and gonorrhea

An Extraordinary Resource for Cancer Care

Support. Connect. Inspire. CNIB s Peer Support and Mentorship Programs

CancerUpdateDFW. From Cancer to Health TM. A Biobehavioral Intervention for Cancer Patients. In this Issue. Winter Volume

Strategy Registered Charity

REPORT. A Model Clinical Trials System for the 21st Century

Baylor Health's Strategy for Advancing Healthcare and Leveraging the Value of Laboratory Testing

PACGENE. A Research Project funded by the National Cancer Institute. Not for Patient Use (R01 CA 97075)

Strategic Plan

PATIENT S GUIDE. Transforming Cancer Care with Proton Therapy. Is Proton Therapy Right for You?

Spring 2018 Symposium Chairs 10 th Anniversary Event April 3-5, Maui. Precision Oncology Knowledge Networks CI4CC

Partnering in Oncology Sharing a Vision to Help Prolong and Improve Patients Lives. Oncology Therapeutic Area Janssen Research & Development, LLC

Surgery saved my life. Rehab is restoring my future.

The Integration of Palliative Care into Standard Oncology Care. American Society of Clinical Oncology Provisional Clinical Opinion

Connecting the Dots Social Media and Influence. Nancy Benavente Cedars Sinai Medical Center

In Cancer s Genes. Pauline Helle, Co-President of Think Pink McGill

Understanding Molecular Mechanisms of Cancers

VA Recovery Transformation & Local Recovery Coordinators

Vision. Mission. Hopelink s Values. Introduction. A community free of poverty

YMCA of Niagara Strategic Plan ymcaofniagara.org

How to Integrate Peer Support & Navigation into Care Delivery

Society s happiness is a social responsibility

OHSU Knight Cancer Institute Overview and Update

Child Neurology Foundation

It s an exciting time for pharmaceutical companies in the. Oncology Reps New Mantra: Provide Real Value, Maintain Physician Access

CANCER DRUG DEVELOPMENT

ONTARIO CANCER PLAN

Diversity Clinical Research Workshop Invited Faculty

8 th InterAmerican Oncology Conference 'Current Status and Future of Anti-Cancer Targeted Therapies' October 17-18, 2019 Buenos Aires, Argentina

Patient and Public Involvement, Engagement and Participation Strategy NIHR Newcastle Clinical Research Facility

RESEARCH EDUCATION COMMUNITY STRATEGIC PLAN

Vision 2025: Summary

From the director. Joe V. Selby, MD, MPH

Science Report ADVANCES IN CANCER RESEARCH

New Drug development and Personalized Therapy in The Era of Molecular Medicine

Cancer Research in the EU Framework Programmes for RTD

A t the retiring of a distinguished oncology career and after working with thousands of

September MESSAGING GUIDE 547E-EN (317)

Personalising medicine and mainstreaming genomics: the impact on nursing

Ruth McCorkle, PhD; Rebecca Kirch, JD; Kim Thiboldeaux; Julie Taylor; and Mark Gorman

Supplemental Table 1.1: Prostate cancer prognostic tools

Speaker bios Chordoma Community Conference at MD Anderson Cancer Center

Irish Experts Launch Global Report and Call for Increased Focus on Metastatic Breast Cancer

The Changing Landscape of Palliative Care

Day One Wednesday July 19, 2017

Jeff Balser, M.D., Ph.D., President and CEO of Vanderbilt University Medical Center, and Dean, Vanderbilt University School of Medicine.

Connections. Academic and Community Cancer Research United (ACCRU) continues to expand our portfolio of cancer treatment

The Life Raft Group. Building Strategic Alliances

Peter P. Yu (President of American Society of Clinical Oncology, ASCO) Collaboration between ASCO and JSCO: Future Perspective

Community Health Advisors- Utilizing Lay Navigators. Michael Bertram, PhD, MBA Associate Director for Administration

November 12, The Honorable Nancy Pelosi Minority Leader United States House of Representatives

CANCER FREE, SIX YEARS AND COUNTING!

Statistical Considerations for Novel Trial Designs: Biomarkers, Umbrellas and Baskets

2017FACTs. Discover. Care. Believe.

SENTINEL LYMPH NODE BIOPSY FOR PATIENTS WITH EARLY-STAGE BREAST CANCER

PARTNERS FOR A HUNGER-FREE OREGON STRATEGIC PLAN Learn. Connect. Advocate. Partners for a Hunger-Free Oregon. Ending hunger before it begins.

LEADERSHIP PROFILE. CURE Childhood Cancer believes that childhood cancer can be cured in our lifetime. -- CURE Childhood Cancer s Vision

Strategic Directions

A Physician Leader s Role In Becoming A High Performing Health System

Click to edit. Program in the Community

Patrons. For further information please visit

The Connecticut Cancer Partnership

PROGRAM. Educational Session: Genomics 15:00-17:00 Session Chair: Lillian L. Siu, Princess Margaret Cancer Centre, Toronto, ON, Canada

UNMC Nebraska Medicine Strategic Plan

Making social action part of life for all young people by 2020

The Heart Institute Tenth Anniversary Update. October 23, 2017

Alliance Organizational Structure. Trini Ajazi, MM Alliance Chief Administrative Officer Clinical Research Professional Orientation

Creating a Recovery- Oriented System of Care in Florida

PROGRESS UPDATE. The Prayers From Maria Foundation

Clinical Activity and Safety of Anti-PD-1 (BMS , MDX-1106) in Patients with Advanced Non-Small-Cell Lung Cancer

Planning Case Study. Barbara Ann Karmanos Cancer Institute McLaren Health Care Detroit, Michigan

Comparative Effectiveness Research (CER) and Personalized Medicine: Policy, Science, and Business

Caregiver Coalitions What It Takes To Build & Maintain An Active, Thriving Coalition

YMCA Calgary. Strategic Plan

Strategic Plan

CancerBase R E S E A R C H

BUILDING AN INFORMATION PLATFORM FOR CANCER RESEARCH & EVIDENCE-BASED HEALTHCARE

Molecularly Targeted Therapies: Mechanisms of Resistance

Conference Program. Genomic heterogeneity in localized lung cancer Andrew Futreal, The University of Texas MD Anderson Cancer Center, Houston, TX

Adaptive Design of Affordable Clinical Trials Using Master Protocols in the Era of Precision Medicine

T E A M L E A D E R GUIDE

Transcription:

BAYLOR HEALTH CARE SYSTEM ONCOLOGY NETWORK NEWS UPDATE WITH YOUR BHCS ONCOLOGY ANCHORS DONNA BOWERS & ALAN MILLER 1

The Evolution of Cancer Care Slash, burn and poison era Precision Medicine Casting out evil spirits Modern Chemo- Radiotherapy Minimally Invasivesurgery 2

To Provide the Best Possible Chance for Patients We are practicing Precision Medicine and not just talking about it. With each individual we work as hard as possible to find an Achille s heel (target) in a patient s tumor and not just use the next new agent to come along. We are mobilizing all the tools at our disposal to maximize the chances of providing benefit with the next therapy. 3

Breast Cancer Currently all Breast Cancer patients assessed for: ER &PR status, HER2 Expression, EGFR BRCAI and BRCAII expression with appropriate history Currently there are 10 open clinical trials using biomarker data as treatment criteria, & a study collecting biomarker data in triple negative breast cancer. A national study complete genome sequencing of patients with triple negative breast cancer is being led by Baylor s Dr. Joyce O Shaughnessy. The first patient (a Baylor patient) to be sequenced was found to have three unique targets for precision therapy. 14 patients have now been sequenced data being analyzed 4

TRIPLE NEGATIVE BREAST CANCER PATIENT Sequenced and Found Lesions in both PI3K/AKT/mTOR and Ras/MEK/ERK PATIENT TREATED WITH DUAL-TARGETING STRATEGY BASED ON SEQUENCING INFORMATION Before 3/7/11 Post 2 cycles 5/4/11 Patnaik et al. ASCO June 2011 # 2502

medfusion Delivering the Tools 6

Precise and Personal 7

The patient and her doctor tell the story. 8

Dan Von Hoff says, And You Have So Many Great Docs I believe in many instances you have the best clinical investigator talent in the U.S. But not many people know DVH

Clinical Trial Accruals by Tumor Type 300 250 200 273 CY 2009 Total Patient Accrual - 462 CY 2010 Total Patient Accrual - 620 CY 2011 Total Patient Accrual - 372 150 151 138 100 50 0 63 23 80 38 20 8 40 26 71 90 92 3 1 1 1 80 41 52 23 25 15 14 20 25 24 12 4 CY 2009 CY 2010 CY 2011 10

Clinical Trials Accruals by Facility It is our goal to make cancer clinical research available throughout the 350 300 January - August 2011 Baylor & Texas Oncology Intervention Accruals by Facility 333 BHCS. Trials currently available at All Saints, BUMC, Garland, Grapevine and Plano. 250 Infrastructure and trials being added at Irving. 200 The Innovative Clinical Trials Center is being developed at 150 100 50 0 39 24 14 19 Fort Worth Garland Grapevine Plano Sammons BUMC, to bring new therapies at the earliest possible opportunity to our patients. Through BRI new researchers are joining the team, and translational research discoveries being made available to our patients. 11

Source: CY 2009 THCIC Data

Source: CY 2009 THCIC Data

Source: CY 2009 THCIC Data

Oncology Presence Map of North Texas with BHCS locations. Map of State with BHCS and Texas Oncology locations. 15

Nationally Ranked-By Volumes BUMC is 17th out of 100 Hospitals for Inpatient Oncology Volumes More Volume Than: City of Hope Moffitt Cancer Center Roswell Park Cancer Institute Johns Hopkins Northwestern Memorial Hospital Vanderbilt University Medical Center Yale-New Haven Hospital + many others Closing In On: Dana Farber Cancer Institute Mass General Hospital Duke University Medical Center Cedars-Sinai Medical Center Volume Leaders: MD Anderson Memorial Sloan Kettering Mayo Clinic Barnes-Jewish NY-Presbyterian/Columbia and Cornell Medicare Only US News & World Report 16

BHCS Oncology Vision Our vision is for the Baylor Health Care System to be recognized as a worldrenowned destination for cancer-related services. 17

BHCS Oncology Strategy Existing Vital Components: Patient Volumes Cohesive Network Organizational Leadership/Structure Strong physician partnerships Organizational Commitment Community and philanthropic support Passion to succeed by all Strategies: BHCS Oncology Strategic Plan Entity Specific Oncology Strategic Plans Performance Dashboards Structured update and working meetings with various leaders across the system Naming Initiative Moving the Charles A. Sammons Cancer Center name across the system 18

Developing BHCS Oncology Councils NURSING PHYSICIAN ADMINISTRATIVE 19

What Does a BHCS Oncology Network Mean? 20